Compare AbCellera Biologics Inc (ABCL) vs Honeywell International Inc (HON) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Honeywell International Inc — how do they compare? AbCellera Biologics Inc trades at $7.17 (market cap $2.35B), while Honeywell International Inc trades at $221.66 (market cap $71.30B). The key difference: Honeywell International Inc is far larger — about 30.3× AbCellera Biologics Inc's market cap, and Honeywell International Inc pays a 4.23% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | HON | |
|---|---|---|
Market Cap | $2.35B | $71.30B |
Sector | Health | Industrials |
52-Week High | $8.12 | $248.04 |
52-Week Low | $2.78 | $188.14 |
Enterprise Value | $1.99B | $95.65B |
Dividend Yield | — | 4.23% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →
